Department of Urology, Bombay Hospital and Medical Research Centre, Mumbai, India.
Int Braz J Urol. 2018 Mar-Apr;44(2):296-303. doi: 10.1590/S1677-5538.IBJU.2017.0441.
Conventional transperitoneal radical cystectomy (TPRC) is the standard approach for muscle invasive bladder cancer. But, the procedure is associated with significant morbidities like urinary leak, ileus, and infection. To reduce these morbidities, the technique of extraperitoneal radical cystectomy (EPRC) was described by us in 1999. We compared these two approaches and the data accrued forms the basis of this report.
All patients who underwent radical cystectomy for bladder cancer by the author (JNK) with follow-up for at least 5 years were included. A total of 338 patients were studied, with 180 patients in EPRC group and 158 in TPRC group.
There were 3 mortalities within 30 days in TPRC group and one in EPRC group. Early complication rate was 52% and 58% in EPRC and TPRC groups. Urinary leak occurred in 31 (9.2%) patients (13 in EPRC, 18 in TPRC, p=0.19). Gastrointestinal complications like ileus occurred in 9 (5%) patients in EPRC group and in 25 (15.8%) patients in TPRC group, (p<0.001). Wound dehiscence occurred in 29, and 36 patients in EPRC and TPRC groups respectively. The reoperation rate was 6.1% and 12% in EPRC and TPRC groups, (p=0.08). Intestinal obstruction were significantly less in EPRC group (1.7% vs. 7.8% in TPRC group, p=0.002). Uretero-enteric anastomosis stricture was seen in 10 patients (4 in EPRC, 6 in TPRC, p=0.39).
The EPRC is associated with decrease gastrointestinal complications, ease of management of urinary leaks, and low reoperation rates. Thus EPRC appears safe functionally and oncologically.
传统经腹腔根治性膀胱切除术(TPRC)是肌层浸润性膀胱癌的标准治疗方法。但是,该手术与尿漏、肠梗阻和感染等显著的并发症相关。为了减少这些并发症,我们于 1999 年描述了经腹膜外根治性膀胱切除术(EPRC)技术。我们比较了这两种方法,所积累的数据是本报告的基础。
纳入所有由作者(JNK)施行根治性膀胱切除术且随访至少 5 年的膀胱癌患者。共研究了 338 例患者,其中 180 例在 EPRC 组,158 例在 TPRC 组。
TPRC 组 30 天内有 3 例死亡,EPRC 组有 1 例。早期并发症发生率在 EPRC 和 TPRC 组分别为 52%和 58%。31 例(9.2%)患者发生尿漏(EPRC 组 13 例,TPRC 组 18 例,p=0.19)。EPRC 组发生肠梗阻等胃肠道并发症 9 例(5%),TPRC 组 25 例(15.8%),差异有统计学意义(p<0.001)。EPRC 和 TPRC 组的切口裂开分别为 29 例和 36 例。EPRC 和 TPRC 组的再次手术率分别为 6.1%和 12%,差异无统计学意义(p=0.08)。EPRC 组肠粘连发生率较低(1.7%比 TPRC 组 7.8%,p=0.002)。EPRC 和 TPRC 组分别有 4 例和 6 例患者发生输尿管-肠吻合口狭窄,差异无统计学意义(p=0.39)。
EPRC 可减少胃肠道并发症、便于处理尿漏和降低再次手术率。因此,EPRC 在功能和肿瘤学方面是安全的。